Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.

Saved in:
Bibliographic Details
Title: Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Authors: Saleh, Khalil1 (AUTHOR) khalil_saleh@live.com, Daste, Amaury2 (AUTHOR), Martin, Nicolas3 (AUTHOR), Pons-Tostivint, Elvire4 (AUTHOR), Auperin, Anne5 (AUTHOR), Herrera-Gomez, Ruth Gabriela1 (AUTHOR), Baste-Rotllan, Neus1 (AUTHOR), Bidault, Francois6 (AUTHOR), Guigay, Joel3 (AUTHOR), Le Tourneau, Christophe4,7,8 (AUTHOR), Saada-Bouzid, Esma3,9 (AUTHOR), Even, Caroline1 (AUTHOR)
Source: European Journal of Cancer. Nov2019, Vol. 121, p123-129. 7p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2019.08.026